New Liquid QC™ Diabetes Control Stable at 20-25º C for 7 Days

SAN MARCOS, Calif. — May 15, 2008 — Cliniqa^® Corporation is pleased to announce new Liquid QC™ Diabetes Control with open vial stability at 20-25º C for 7 days. Designed for use with immunochemical methodologies, it is stable 18 months from date of manufacture when stored unopened at 2-8º C.  Once opened, Liquid QC Diabetes Control is stable for 30 days when stored at 2-8º C or 7 days at 20-25º C.  The control is intended for use as an assayed quality control material for Hemoglobin A1c and Hemoglobin.  Liquid QC™ Diabetes Control is available in several Bi-Level kit configurations of 1 mL and 0.5 mL.   It is assayed for the most popular platforms including the Beckman Coulter Synchron CX/LX/DxC Systems, Horiba ABX Pentra, Olympus AU Systems, Roche Hitachi/Integra/Mira and Modular Systems, Siemens Advia  Chemistry Systems, DCA 2000 Systems and Dimension Series, as well as the Vital Diagnostics Envoy.

About CLINIQA

CLINIQA, an ISO 9000/13485 certified company, is a clinical diagnostics company specializing in OEM and branded controls, calibrators and linearity calibration verifiers featuring proprietary True Liquid Control Technology.  Through recent acquisitions CLINIQA now offers OEM proficiency test materials and Raichem reagents, standards and calibrators.  CLINIQA is also the co-founder of the “The Quality Alliance” formed to provide a range of innovative quality control products and an online Quality Analysis Peer Review application, InterQC, through common distribution channels in Europe, the U.S.A and Asia.

To learn more about the complete range of CLINIQA products, please visit www.cliniqa.com or contact the U.S. headquarters office: